role of pd-l1 status in mrcc
Published 6 years ago • 38 plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
2:11
pd-l1 testing in mrcc
-
0:48
expert discusses the role of pd-l1 expression as a predictive biomarker in urothelial carcinoma
-
0:48
dr. pal discusses the role of pd-l1 in metastatic rcc
-
1:38
treatment for frail or pd-l1–positive mrcc
-
6:08
pd-1, pd-l1 role in immune system inhibition
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
1:53
dr. brahmer on the role of pd-1 and pd-l1
-
2:23
importance of pd-l1 expression in kidney cancer
-
3:29
pd-l1 status: what is the current role?
-
1:25
the future role of pd-l1 testing in lung cancer
-
7:13
role of pd-l1 testing in kidney cancer
-
5:18
pd-l1 expression as a biomarker in renal cell carcinoma
-
2:19
combining ctla-4 agents with pd-1/pd-l1 agents in lung cancer
-
4:16
nsclc treatment: low pd-l1 status and chemotherapy
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
4:53
the role of immunotherapy in cancer treatment (pd-l1 overview)
-
3:29
pd-l1/pd-1 pathway: a security checkpoint
-
1:07
the role of pd-1 inhibitors in liver cancer
-
1:25
dr. mcdermott discusses pd-l1 expression in kidney cancer
-
2:23
understanding the role of clinical trials in renal cell carcinoma
-
2:27
role for everolimus in mrcc treatment?